Linaclotide vs Teduglutide
Head-to-head comparison of Linaclotide (Linaclotide) and Teduglutide (Teduglutide (glycyl-2 human glucagon-like peptide-2 analog)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Linaclotide | Teduglutide |
|---|---|---|
| Category | Gastrointestinal | Gastrointestinal |
| Full Name | Linaclotide | Teduglutide (glycyl-2 human glucagon-like peptide-2 analog) |
| Molecular Weight | 1526.8 Da | 3752 Da |
| Half-Life | Active locally; negligible systemic half-life | approximately 2-3 hours |
| Amino Acids | 14 | 33 |
| Typical Dose | 72-290 mcg once daily | 0.05 mg/kg/day |
| Route | Oral | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 1200 | 300 |
| Research Status | Clinical | Clinical |
Linaclotide Benefits
- ✓improves-bowel-movements
- ✓reduces-abdominal-pain
- ✓increases-intestinal-secretion
- ✓supports-transit
Teduglutide Benefits
- ✓mucosal-growth
- ✓absorption-support
- ✓barrier-repair
- ✓intestinal-adaptation
Linaclotide Dosing
72 mcg PO daily|145 mcg PO daily|290 mcg PO daily
Teduglutide Dosing
0.05 mg/kg once daily subcutaneous injection|chronic maintenance dosing in approved use|monitor fluid status and intestinal anatomy
Linaclotide Side Effects
- ⚠diarrhea
- ⚠abdominal-pain
- ⚠bloating
Teduglutide Side Effects
- ⚠abdominal pain
- ⚠fluid retention
- ⚠polyp/neoplasia monitoring needed
Research Overview
Linaclotide
Linaclotide has extensive clinical evidence for chronic idiopathic constipation and IBS-C, with consistent effects on stool frequency and abdominal symptom relief. Its mechanism is local GC-C activation in the gut with minimal systemic exposure.
Teduglutide
Teduglutide has robust clinical evidence showing improved intestinal absorption and reduced parenteral nutrition dependence in short bowel syndrome. Its mechanism, via GLP-2 receptor activation, makes it highly relevant to mucosal healing and intestinal adaptation research.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.